Literature DB >> 2886866

Can HTLV-1 lead to immunological disease?

J C Vernant, G G Buisson, G Sobesky, S Arfi, G Gervaise, G C Román.   

Abstract

Entities:  

Mesh：

Year:  1987        PMID： 2886866     DOI： 10.1016/s0140-6736(87)92431-7

Source DB:  PubMed          Journal:  Lancet        ISSN： 0140-6736            Impact factor:   79.321


× No keyword cloud information.
  5 in total

1.  Human T-lymphotropic virus type I or II (HTLV-I/II) associated with recurrent longitudinally extensive transverse myelitis (LETM): two case reports.

Authors:  Silvia R Delgado; William A Sheremata; Andrew D Brown; Micheline McCarthy
Journal:  J Neurovirol       Date:  2010-05       Impact factor: 2.643

2.  Antibodies to HTLV-I in sera from patients with connective tissue diseases.

Authors:  W Irvine; P White; G Cambridge
Journal:  Ann Rheum Dis       Date:  1989-01       Impact factor: 19.103

Review 3.  Exosomes and their role in CNS viral infections.

Authors:  Gavin C Sampey; Shabana S Meyering; Mohammad Asad Zadeh; Mohammed Saifuddin; Ramin M Hakami; Fatah Kashanchi
Journal:  J Neurovirol       Date:  2014-02-28       Impact factor: 2.643

4.  The occurrence of systemic lupus erythematosus in an asymptomatic carrier of human T-cell lymphotropic virus type I.

Authors:  Toshiro Sugimoto; Mihoko Okamoto; Tetsuro Koyama; Hiroyuki Takashima; Mitsuo Saeki; Atsunori Kashiwagi; Minoru Horie
Journal:  Clin Rheumatol       Date:  2006-03-25       Impact factor: 3.650

5.  Detection of human T lymphotrophic virus type I (HTLV-I) proviral DNA and analysis of T cell receptor V beta CDR3 sequences in spinal cord lesions of HTLV-I-associated myelopathy/tropical spastic paraparesis.

Authors:  H Hara; M Morita; T Iwaki; T Hatae; Y Itoyama; T Kitamoto; S Akizuki; I Goto; T Watanabe
Journal:  J Exp Med       Date:  1994-09-01       Impact factor: 14.307
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.